Date: September 4, 2020
Time: 8:00am (PDT), 11:00am (EDT)
Direct detection of viral RNA in human or other animal cells by RNA in situ hybridization (ISH) technology is a powerful tool to establish the etiology and pathogenesis of viral disease. Nucleic acid-based molecular detection methods have revolutionized viral detection, offering several essential advantages such as sensitivity, specificity, and speed. Beyond this, RNAscope ISH technology uniquely offers a molecular detection at a single cell resolution coupled with morphological context to enable visualization of the virus in different infected tissues and cell types. In this webinar, we will demonstrate how RNAscope technology can be used to detect viral infection and pathogenesis for research, and enhance our understanding of globally important viruses, such as SARS-CoV-2. For research labs that require high throughput and automated RNA in situ hybridization (ISH) technology on BOND RX, Bio-Techne has partnered with Leica Biosystems to deliver RNAscope® ISH automated assays.* Here we present the Bio-Techne products and technical suggestions to successfully execute RNAScope technology on BOND RX stainer from Leica Biosystems.
- RNAScope Technology Overview - Learn how the RNAScope technology works and why it is great on the Leica BOND RX Research Platform
- See the proof - publications that show how COVID-19 Detection and Probes deliver the results researchers seek
- Learn about the COVID-19 Offerings (Bio-Techne) on the BOND RX stainer from Leica Biosystems
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES
*Performance claims of the probes for those assays have not been established
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.